THE ROLE OF BETA-BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN PREGNANT WOMEN

Show other versions (1)

<p>Highly selective β-adrenoblockers (β-AB) are used in pregnant women with cardiovascular diseases (arterial hypertension, arrhythmia, Marfan syndrome, hypertrophic cardiomyopathy). β-AB fall into the category C according to safety classification of Food and Drug Administration (US FDA). Thei...

Full description

Bibliographic Details
Published in:Рациональная фармакотерапия в кардиологии
Main Authors: R. I. Striuk, Ya. V. Brytkova
Format: Article
Language:English
Published: Столичная издательская компания 2015-12-01
Subjects:
β-адреноблокаторы
беременность
безопасность для плода
артериальная гипертония
аритмии
синдром Марфана
гипертрофическая кардиомиопатия
Online Access:http://www.rpcardio.ru/jour/article/view/585
Description
Summary:<p>Highly selective β-adrenoblockers (β-AB) are used in pregnant women with cardiovascular diseases (arterial hypertension, arrhythmia, Marfan syndrome, hypertrophic cardiomyopathy). β-AB fall into the category C according to safety classification of Food and Drug Administration (US FDA). Their prescription in different clinical situations meets the principle of "risk–benefit". Fetus and newborn status should be monitored because β-AB can cause bradycardia, hypoglycemia, apnea and metabolic disorders. The risk of these side effects is extremely low, while β-AB clinical efficacy is high.</p>
ISSN:1819-6446
2225-3653

Similar Items